Evidence map›Paper›PMID 23874031›Full record

ArticleTransactions of the American Clinical and Climatological Association2013

The lung in liver disease: old problem, new concepts.

Michael B Fallon, Junlan Zhang

Open access · greenAbstract read
In one paragraph

Article in Transactions of the American Clinical and Climatological Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Hepatopulmonary Syndrome.Digestive diseases and sciences · 2015
    Review
  5. Article
  6. Hypoxia among patients on the liver-transplant waiting list.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
    Article
  7. The hepatopulmonary syndrome.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael B FallonDepartment of Internal Medicine, Division of Gastroenterology, Hepatology & Nutrition, The University of Texas Medical School at Houston, 6431 Fannin Street, MSB 4.234, Houston, Texas 77030, USA. Michael.B.Fallon@uth.tmc.edu
Junlan Zhang
The University of Texas Health Science Center at Houston · US

Funding

Estrogen signaling in portopulmonary hypertensionR01HL113988 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FALLON, MICHAEL TODD, KAWUT, STEVEN M · 2012 to 2016
$3.8M
MEDIATORS OF PULMONARY VASODILATATION IN LIVER DISEASER01DK056804 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FALLON, MICHAEL B · 2000 to 2013
$3.6M
NHLBI NIH HHS 1R01HL113988NHLBI NIH HHS R01 HL113988NIDDK NIH HHS R01 DK056804PHS HHS 5DKR01DK056804
6 · The paper itself

Abstract

Liver dysfunction has been recognized to influence the lung in many different clinical situations, although the mechanisms for these effects are not well understood. One increasingly recognized interaction, the hepatopulmonary syndrome (HPS) occurs in the context of cirrhosis and results when alveolar microvascular dilation causes arterial gas exchange abnormalities and hypoxemia. HPS occurs in up to 30% of patients with cirrhosis and significantly increases mortality in affected patients. Currently, liver transplantation is the only curative therapy. Experimental biliary cirrhosis induced by common bile duct ligation (CBDL) in the rat reproduces the pulmonary vascular and gas exchange abnormalities of human HPS and has been contrasted with other experimental models of cirrhosis in which HPS does not develop. Microvascular dilation, intravascular monocyte infiltration, and angiogenesis in the lung have been identified as pathologic features that drive gas exchange abnormalities in experimental HPS. Our recent studies have identified biliary epithelium and activation and interaction between the endothelin-1 (ET-1)/endothelial endothelin B (ETB) receptor and CX3CL1/CX3CR1 pathways as important mechanisms for the observed pathologic events. These studies define novel interactions between the lung and liver in cirrhosis and may lead to effective medical therapies.

Indexed as

AnimalsCells, CulturedCytokinesEndothelin-1Gene Expression RegulationHepatopulmonary SyndromeHumansRatsCytokinesEndothelin-1

Identifiers

PMID23874031
PMCPMC3715896
OpenAlexW1950069712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.